Table 6.
Cofactors: | β | Adjusted β | OR | 95% CI [LB, UB] | p-value |
---|---|---|---|---|---|
Structural factor model: | |||||
Age | 0.028 | 0.027 | 0.974 | [0.958, 0.989] | 0.001 |
Gender (males) | −0.322 | −0.088 | 1.092 | [0.689, 1.728] | 0.709 |
Septal deviation | −0.846 | −0.518 | 1.679 | [1.004, 2.808] | 0.048 |
Nasal polyposis | 1.734 | 1.692 | 0.184 | [0.116, 0.292] | <0.001 |
Inflammatory factor model: | |||||
Age | 0.028 | 0.028 | 1.029 | [1.012, 1.045] | 0.001 |
Gender (males) | −0.322 | −0.136 | 0.873 | [0.547, 1.394] | 0.570 |
Nasal polyposis | 1.734 | 1.497 | 4.467 | [2.768, 7.206] | <0.001 |
Recalcitrant disease | 0.972 | 0.614 | 1.847 | [1.138, 3.000] | 0.013 |
ASA intolerance | 1.633 | 1.102 | 3.011 | [1.314, 6.897] | 0.009 |
β, beta effect estimate. S.E., standard error. OR, odds ratio. CI, confidence interval. LB, lower bound. UB, upper bound. ASA, acetylsalicyclic acid. Nasal polyposis was evaluated as both a structural and inflammatory variable while both models were adjusted for age and gender (male reference group).